Literature DB >> 7983765

Major histocompatibility complex class I-restricted cytotoxic T-lymphocyte responses in horses infected with equine herpesvirus 1.

G Allen1, M Yeargan, L R Costa, R Cross.   

Abstract

An experimental system that permits sensitive and reproducible detection of equine herpesvirus 1 (EHV-1)-specific cytotoxic T-lymphocyte (CTL) activity in the horse was developed. Peripheral blood mononuclear cells (PBMC) collected from immune horses were restimulated in vitro by culture with live EHV-1. Cytotoxic activity against virus-infected, pokeweed mitogen-stimulated lymphoblast targets was assessed in a 4-h 51Cr release assay. The optimal conditions for in vitro stimulation of equine memory CTLs and for preparation of EHV-1-infected target cells expressing viral antigens were systematically identified by individually testing the effects of variations in responder cell concentration, culture medium composition, serum type, incubation time, antigen form, and exogenous mediator content. By using this optimized system for generation and assay of equine CTLs, the development of EHV-1-specific cytotoxic responses in 12 horses was evaluated after experimental viral infection. CTLs with the capacity for killing EHV-1-infected target cells were detected in equine PBMC as early as 1 week postinfection, reached maximal levels by 2 to 3 weeks, and remained detectable for a year after infection. Equine effector cells mediating lysis of EHV-1-infected targets were predominantly CD8+ T lymphocytes, and the cytotoxicity was specific for virus and restricted by major histocompatibility complex class I molecules. The results define a reliable and convenient experimental system for generation and assay of EHV-1 CTLs which can now be used for more-detailed characterization of the equine CTL response to infection by this herpesvirus pathogen.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7983765      PMCID: PMC188619          DOI: 10.1128/JVI.69.1.606-612.1995

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Pathological findings in horses dying during an outbreak of the paralytic form of Equid herpesvirus type 1 (EHV-1) infection.

Authors:  K E Whitwell; A S Blunden
Journal:  Equine Vet J       Date:  1992-01       Impact factor: 2.888

2.  Cell mediated immunity in equine herpesvirus type 1 infection I. In vitro lymphocyte blastogenesis and serum neutralization antibody in normal parturient and aborting mares.

Authors:  S K Dutta; D L Campbell
Journal:  Can J Comp Med       Date:  1977-10

3.  Paralysis of horses associated with equine herpesvirus 1 infection.

Authors:  T Jackson; J W Kendrick
Journal:  J Am Vet Med Assoc       Date:  1971-04-15       Impact factor: 1.936

Review 4.  Molecular epizootiology, pathogenesis, and prophylaxis of equine herpesvirus-1 infections.

Authors:  G P Allen; J T Bryans
Journal:  Prog Vet Microbiol Immunol       Date:  1986

5.  The Equine Virology Research Foundation--a view from abroad.

Authors:  G P Allen
Journal:  Equine Vet J       Date:  1994-07       Impact factor: 2.888

6.  Clinical report of a paralytic syndrome affecting stallions, mares and foals on a thoroughbred studfarm.

Authors:  R E Greenwood; A R Simson
Journal:  Equine Vet J       Date:  1980-07       Impact factor: 2.888

7.  Equine herpesvirus type 1 (EHV-1) induced abortions and paralysis in a Lipizzaner stud: a contribution to the classification of equine herpesviruses.

Authors:  S I Chowdhury; G Kubin; H Ludwig
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

8.  Viraemia and abortions are not prevented by two commercial equine herpesvirus-1 vaccines after experimental challenge of horses.

Authors:  F Bürki; W Rossmanith; N Nowotny; C Pallan; K Möstl; H Lussy
Journal:  Vet Q       Date:  1990-04       Impact factor: 3.320

9.  Trials of an inactivated equid herpesvirus 1 vaccine: challenge with a subtype 2 virus.

Authors:  J A Mumford; J Bates
Journal:  Vet Rec       Date:  1984-04-14       Impact factor: 2.695

10.  Identification and genetics of horse lymphocyte alloantigens.

Authors:  E Bailey
Journal:  Immunogenetics       Date:  1980       Impact factor: 2.846

View more
  22 in total

1.  Intramuscular Immunization of Mice with the Live-Attenuated Herpes Simplex Virus 1 Vaccine Strain VC2 Expressing Equine Herpesvirus 1 (EHV-1) Glycoprotein D Generates Anti-EHV-1 Immune Responses in Mice.

Authors:  Shiliang A Liu; Brent A Stanfield; Vladimir N Chouljenko; Shan Naidu; Ingeborg Langohr; Fabio Del Piero; Jacqueline Ferracone; Alma A Roy; Konstantin G Kousoulas
Journal:  J Virol       Date:  2017-05-26       Impact factor: 5.103

2.  Selecting peptides to optimize Th1 responses to an equine lentivirus using HLA-DR binding motifs and defined HIV-1 Th peptides.

Authors:  Darrilyn G Fraser; Robert H Mealey; Travis C McGuire
Journal:  Immunogenetics       Date:  2003-08-27       Impact factor: 2.846

3.  Immunization with Attenuated Equine Herpesvirus 1 Strain KyA Induces Innate Immune Responses That Protect Mice from Lethal Challenge.

Authors:  Seong K Kim; Akhalesh K Shakya; Dennis J O'Callaghan
Journal:  J Virol       Date:  2016-08-26       Impact factor: 5.103

4.  An Equine Herpesvirus Type 1 (EHV-1) Ab4 Open Reading Frame 2 Deletion Mutant Provides Immunity and Protection from EHV-1 Infection and Disease.

Authors:  Christiane L Schnabel; Susanna Babasyan; Alicia Rollins; Heather Freer; Christine L Wimer; Gillian A Perkins; Fahad Raza; Nikolaus Osterrieder; Bettina Wagner
Journal:  J Virol       Date:  2019-10-29       Impact factor: 5.103

5.  Specific cytotoxic T lymphocytes are involved in in vivo clearance of infectious bronchitis virus.

Authors:  S H Seo; E W Collisson
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

6.  Lymphocyte proliferation responses induced to broadly reactive Th peptides did not protect against equine infectious anemia virus challenge.

Authors:  Darrilyn G Fraser; Steve R Leib; Bao Shan Zhang; Robert H Mealey; Wendy C Brown; Travis C McGuire
Journal:  Clin Diagn Lab Immunol       Date:  2005-08

7.  Characterization of the cytolytic T-lymphocyte response to a candidate vaccine strain of equine herpesvirus 1 in CBA mice.

Authors:  P M Smith; Y Zhang; S R Jennings; D J O'Callaghan
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

8.  Interferon-gamma, interleukin-4 and interleukin-10 production by T helper cells reveals intact Th1 and regulatory TR1 cell activation and a delay of the Th2 cell response in equine neonates and foals.

Authors:  Bettina Wagner; Alexandra Burton; Dorothy Ainsworth
Journal:  Vet Res       Date:  2010-04-09       Impact factor: 3.683

9.  Cloning and large-scale expansion of epitope-specific equine cytotoxic T lymphocytes using an anti-equine CD3 monoclonal antibody and human recombinant IL-2.

Authors:  Robert H Mealey; Matt H Littke; Steven R Leib; William C Davis; Travis C McGuire
Journal:  Vet Immunol Immunopathol       Date:  2007-04-08       Impact factor: 2.046

10.  Generation of a candidate live marker vaccine for equine arteritis virus by deletion of the major virus neutralization domain.

Authors:  Javier Castillo-Olivares; Roeland Wieringa; Tamás Bakonyi; Antoine A F de Vries; Nick J Davis-Poynter; Peter J M Rottier
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.